B+
Bull case
25%
Probability
Target price
$8.00
+29.0% vs current
LFVN
LifeVantageDNasdaq / Household & Personal Products
Last Price
At close
2026-07-18
AI scenario view
RankAlpha Sentiment CodexMost likely
B
Base case
50%
Probability
Target price
$6.50
+4.8% vs current
B-
Bear case
25%
Probability
Target price
$4.75
-23.4% vs current
AI sentiment snapshot
Latest data as of 2026-07-07
Recent news sentiment (30D)
-0.4
Mixed
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Sentiment proxy
+49.7
Score
AI commentary
Primary-source evidence is strong but concentrated in the May 6, 2026 company earnings release furnished via 8-K, and that source was clearly negative on revenue, margins, and near-term outlook. Recent packet news is sparse and mostly tied to the earnings reset. Verified post-print price reaction, broad analyst estimate revisions, options positioning, and social coverage are unavailable here, so this remains a low-coverage monitoring name rather than a high-conviction turnaround.
RankAlpha Sentiment Codex - 2026-07-07
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-05-06eventQ3 FY26 reset and low-end FY26 framing were formally confirmedHigh impact
LifeVantage's May 6, 2026 earnings release furnished with its 8-K reported Q3 revenue of $43.7M, down 25.2% year over year, adjusted EBITDA of $3.2M versus $6.4M, and said fiscal 2026 revenue, adjusted EBITDA, and adjusted EPS should be close to the lower end of prior guidance; management tied the shortfall mainly to weaker MindBody GLP-1 System sales, only partly offset by LoveBiome. [#SEC-8K-2026-05-06]
2026-09-30catalystNext reporting window must show product-mix stabilization and less margin pressureMedium impact
The same company release showed Americas revenue down 28.9% and gross margin down to 79.0% from 81.0%, with pressure from MindBody GLP-1 weakness, inventory obsolescence, and higher shipping and warehouse expense. A later filing or release needs to show LoveBiome and the broader portfolio can offset that demand hole without further margin erosion. [#SEC-8K-2026-05-06]
2026-12-31catalystCash, no debt, buyback capacity and dividend support downside resilienceHigh impact
As of March 31, 2026, the company reported $12.5M of cash, no debt outstanding, about $59.0M remaining on its repurchase authorization, and an increased quarterly dividend, which gives management some time to work through the current sales reset even though it does not by itself restore growth. [#SEC-8K-2026-05-06]
Recommendation
N/A
No formal recommendation provided.
As of 2026-07-07 • Updated nightlySource: Internal modelMethodology